Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ITF2984 in Acromegalic Patients
NCT02111044Phase 2Completed
- Sponsor
- Italfarmaco
- Start
- Apr 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules, Modified Peptides, Native Peptides
- Countries
- 9
01
Overview
A Phase 2 trial of ITF2984 in acromegaly, sponsored by Italfarmaco. Started Apr 2014; status: completed.
02
Drugs
ITF2984
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT02111044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02111044.